Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $30.1200 (-1.15%) ($30.1200 - $30.1200) on Fri. Apr. 16, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.82% (three month average) | RSI | 62 | Latest Price | $30.1200(-1.15%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -0.1% a day on average for past five trading days. | Weekly Trend | IOVA declines -0.8% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(46%) XBI(42%) ARKG(40%) IWO(40%) IWC(38%) | Factors Impacting IOVA price | IOVA will decline at least -1.91% in a week (0% probabilities). VIXM(-23%) UUP(-16%) VXX(-11%) TBT(-5%) UNG(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.91% (StdDev 3.82%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $23.57(-21.75%) | Inflection Point | Yes | Resistance Level | $30.68 | 5 Day Moving Average | $30.04(0.27%) | 10 Day Moving Average | $30.64(-1.7%) | 20 Day Moving Average | $30.68(-1.83%) | To recent high | -42.7% | To recent low | 5.1% | Market Cap | $4.411b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |